Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical and Experimental Medicine"
DOI: 10.1007/s10238-018-00542-7
Abstract: Graves’ disease is an organ-specific autoimmune disease with hyperthyroidism, diffuse goiter and autoantibodies against TSH receptor, thyroid peroxidase (TPO) and/or thyroglobulin (Tg). Graves’ hyperthyroidism is characterized by T3 dominance due to the conversion of T4…
read more here.
Keywords:
peptide antibodies;
type deiodinase;
antithyroid drugs;
dio2 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "International journal of endocrinology"
DOI: 10.1155/2023/9935195
Abstract: Objective To study the risk factors for granulocytopenia caused by antithyroid drugs. Methods Patients who were diagnosed with Graves' hyperthyroidism and regularly treated with antithyroid drugs (ATDs) from January 2010 to July 2022 at Nanjing…
read more here.
Keywords:
antithyroid drugs;
granulocytopenia patients;
risk factors;
risk ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of feline medicine and surgery"
DOI: 10.1177/1098612x221091738
Abstract: OBJECTIVES The objective of this study was to evaluate the presence of traces of thiamazole in the urine of owners of hyperthyroid cats treated with antithyroid drugs. METHODS Urine was collected from 24 owners of…
read more here.
Keywords:
owners hyperthyroid;
antithyroid drugs;
thiamazole;
hyperthyroid cats ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Endokrynologia Polska"
DOI: 10.5603/ep.a2020.0007
Abstract: PURPOSE The outcome of medical treatment in patients with Graves' disease (GD) is generally difficult to predict. In this study, we examined the hypothesis that gender may affect the outcome of treatment with antithyroid drugs…
read more here.
Keywords:
poorly controlled;
study;
antithyroid drugs;
relapse poorly ... See more keywords